| Overview |
| bsm-62902r |
| JNK1/3 Recombinant Antibody |
| WB, IHC-P, IHC-F, IP, IF |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human JNK1 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 5599 |
| P45983,P53779 |
| c-Jun N-terminal kinase 3; FLJ12099; FLJ33785; JNK1; JNK3; JNK3 alpha protein kinase; JNK3A; MAP kinase 10; MAP kinase p49 3F12; MAPK 10; MAPK10. |
| Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. |
| Application Dilution |
| WB |
=1:500-1:2000 |
| IHC-P |
IHC-P=1:100-500 |
| IHC-F |
IHC-F=1:100-500 |
| IP |
IP=1:20-1:50 |
| IF |
IF=1:100-500 |